{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-181717","form_type":"8-K","ticker":"SLNO","cik":"0001484565","company_name":"SOLENO THERAPEUTICS INC","filed_at":"2024-07-19T23:59:59+00:00","discovered_at":"2026-05-14T18:03:13.209957+00:00","generated_at":"2026-05-31T19:00:19.357084+00:00","sec_items":["1.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Soleno Therapeutics enters $150M at-the-market equity offering with Jefferies","bullets":["Soleno may sell up to $150M of common stock from time to time under Sale Agreement with Jefferies.","Jefferies will use commercially reasonable efforts to sell shares as an at-the-market offering.","Commission of 3.0% of gross proceeds; Soleno also reimburses certain expenses.","Offering made under existing S-3ASR registration statement filed on Jan 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-181717","json":"https://secwatch.observer/filing/0001193125-24-181717.json","markdown":"https://secwatch.observer/filing/0001193125-24-181717.md","text":"https://secwatch.observer/filing/0001193125-24-181717.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1484565/000119312524181717/0001193125-24-181717-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1484565/000119312524181717/d817873d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T19:00:19.357084+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}